Indications

Source of probiotics. Helps support gastrointestinal health. Could promote a
favorable gut flora.

Ingredients

EACH CAPSULE CONTAINS/ CHAQUE CAPSULE CONTIENT: Probiotic Consortium/ Consortium probiotique........................................................40 billion CFU/ milliards d’UFC Bifidobacterium animalis subsp. lactis (CUL-34) & Bifidobacterium bifidum (CUL-20)...................................16 billion CFU/ milliards d’UFC Bifidobacterium breve (CUL-74).............................................12 billion CFU/ milliards d’UFC Bifidobacterium animalis subsp. lactis (Bl-04).......................8 billion CFU/ milliards d’UFC Bifidobacterium longum subsp. longum (CUL-75)................... 2 billion CFU/ milliards d’UFC Bifidobacterium longum subsp. infantis (Bi-26)...................... 2 billion CFU/ milliards d’UFC

Non-Medicinal Ingredients: Cellulose, hypromellose, stearic acid
IngrÉdients non mÉdicinaux : Cellulose, hypromellose, acide stÉarique

Description

Six-strain Bifidobacteria combination


Provides 40 billion CFU per dose

Convenient once-daily capsule format

Supports gastrointestinal health

Includes proprietary, research-driven strains








HMF Bifido Capsules offer six proprietary Bifidobacteria strains to support probiotic colonization in the large intestine.1

Bifidobacteria are normally present in the gut from birth to old age, where they play an important role in gastrointestinal health.2

Bifidobacteria help to mediate carbohydrate fermentation in the large intestine and contribute to the production of important short-chain fatty acids (SCFAs), including acetate and lactate.3

Although they are the most abundant genus present in the guts of healthy infants, Bifidobacteria concentrations decrease as individuals age, with greatest declines observed in the elderly.2

Clinical research suggests that Bifidobacteria supplementation can promote a healthy gut flora composition and support gastrointestinal health.3

HMF Bifido Capsules provide highly researched probiotic strains such as Bl-04, along with CUL-34 and CUL-20, which have been demonstrated in clinical trials to contribute to a favourable gut flora. < sup > 4-6 < /sup >








REFERENCES



1. Govender, M, Choonara, YE, Kumar, P, du Toit, LC, van Vuuren, S, Pillay, V. AAPS PharmSciTech. 2014; 15(1): 29-43.


2. Arboleya, S, Watkins, C, Stanton, C, Ross, RP. Front Microbiol. 2016; 7: 1204.


3. Bottacini, F, van Sinderen, D, Ventura, M. Biochem J. 2017; 474(24): 4137-4152.


4. Madden, JA, Plummer, SF, Tang, J, Garaiova, I, Plummer, NT, Herbison, M, Hunter, JO, Shimada, T, Cheng, L, Shirakawa, T. Int Immunopharmacol. 2005; 5(6): 1091-1097.


5. Plummer, SF, Garaiova, I, Sarvotham, T, Cottrell, SL, Le Scouiller, S, Weaver, MA, Tang, J, Dee, P, Hunter, J. Int J Antimicrob Agents. 2005; 26(1): 69-74.


6. Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. Aliment Pharmacol Ther. 2009; 29(1): 97-103.

Quantity

30

Dose

Recommended Dose: Adults, Adolescents and Children (6 years and older): Take 1 capsule daily or as recommended by your healthcare practitioner. Take at least 2 to 3 hours before or after taking antibotics.

Potential side effects/Safety

Risk Information: Do not use this product if you have an immune-compromised
condition or are taking tetracycline. Consult your healthcare practitioner prior to use if you have
fever, vomiting, bloody diarrhoea or severe abdominal pain. Stop use and consult your healthcare
practitioner if symptoms of digestive upset occur, worsen, or persist beyond 3 days.